Download from app store
We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.

Journal Scan / Research · March 19, 2023

Comparison of Insulin Glargine 300 U/mL and Insulin Degludec 100 U/mL Around Spontaneous Exercise Sessions in Adults With Type 1 Diabetes

Diabetes Technology & Therapeutics

 

Additional Info

Diabetes Technology & Therapeutics
Comparison of Insulin Glargine 300 U/mL and Insulin Degludec 100 U/mL Around Spontaneous Exercise Sessions in Adults with Type 1 Diabetes: A Randomized Cross-Over Trial (ULTRAFLEXI-1 Study)
Diabetes Technol. Ther. 2023 Mar 01;25(3)161-168, O Moser, A Müller, F Aberer, F Aziz, H Kojzar, C Sourij, A Obermayer, F Abbas, P Birnbaumer, J Lenz, I Mursic, C Sternad, L Hönger, H Ziko, PN Pferschy, N Tripolt, H Sourij

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.

Further Reading